StockDocs
Project by Matthew Castle Please send feedback to matthewgcastle@gmail.com
TELA

TELA Bio, Inc.

TELA Nasdaq Surgical & Medical Instruments & Apparatus EDGAR ↗
$0.74
+0.01 +1.37%

Key statistics

from XBRL data in SEC filings
Market cap
$33.1M
Revenue (TTM)
$80.8M
Net income (TTM)
-$39.8M
EPS (TTM)
$-0.79
P/E ratio
Dividend yield
Free cash flow
-$28.7M
Cash
$39.5M
Total assets
$69.9M
Gross margin
67.3%
52-week range
$0.50 – $2.14

Recent SEC filings

40 most recent
Annual, quarterly & current reports
8-K Director or officer change Aug 4, 2026 8-K Director or officer change; Shareholder vote results Jun 11, 2026 10-Q Quarter ended 2026-03-31 May 13, 2026 8-K Results of operations (earnings release); Regulation FD disclosure May 12, 2026 8-K Results of operations (earnings release); Director or officer change Apr 30, 2026 10-K Fiscal year ended 2025-12-31 Mar 25, 2026 8-K Results of operations (earnings release); Regulation FD disclosure Mar 24, 2026 8-K Delisting notice or listing-rule failure Mar 20, 2026 8-K Entered a material agreement; Terminated a material agreement; Took on a direct financial obligation; Unregistered sale of equity Nov 14, 2025 10-Q Quarter ended 2025-09-30 Nov 14, 2025 8-K Results of operations (earnings release); Regulation FD disclosure Nov 13, 2025 8-K Director or officer change Nov 3, 2025 8-K Director or officer change Oct 9, 2025 10-Q Quarter ended 2025-06-30 Aug 11, 2025 8-K Results of operations (earnings release); Regulation FD disclosure Aug 11, 2025 8-K Director or officer change; Regulation FD disclosure Jun 2, 2025 8-K Director or officer change; Shareholder vote results May 30, 2025 10-Q Quarter ended 2025-03-31 May 8, 2025 8-K Results of operations (earnings release); Regulation FD disclosure May 8, 2025 8-K Other events Mar 31, 2025 10-K Fiscal year ended 2024-12-31 Mar 21, 2025 8-K Results of operations (earnings release); Regulation FD disclosure Mar 20, 2025 10-Q Quarter ended 2024-09-30 Nov 8, 2024 8-K Results of operations (earnings release); Regulation FD disclosure Nov 7, 2024 8-K Entered a material agreement Oct 23, 2024 8-K Results of operations (earnings release); Regulation FD disclosure Oct 22, 2024 10-Q Quarter ended 2024-06-30 Aug 13, 2024 8-K Results of operations (earnings release); Regulation FD disclosure Aug 12, 2024 8-K Director or officer change; Shareholder vote results; Other events Jun 6, 2024 8-K Other events May 20, 2024 10-Q Quarter ended 2024-03-31 May 10, 2024 8-K Results of operations (earnings release); Regulation FD disclosure May 9, 2024 8-K Other events Apr 15, 2024 10-K Fiscal year ended 2023-12-31 Mar 22, 2024 8-K Results of operations (earnings release); Regulation FD disclosure; Other events Mar 21, 2024 8-K Other events Mar 20, 2024 10-Q Quarter ended 2023-09-30 Nov 13, 2023 8-K Results of operations (earnings release); Regulation FD disclosure Nov 9, 2023 8-K Entered a material agreement Oct 20, 2023 8-K Director or officer change Sep 28, 2023